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INTRODUCTION
ALTHOUGH SIESTA (AFTERNOON OR MIDDAY NAP) IS A 
COMMON TRADITION IN MEDITERRANEAN REGIONS, 
SURVEYS HAVE SHOWN IT TO BE A PREVALENT feature 
of adult sleep-wake activity in other locales as well, including 
the United States, Australia, Nigeria, and the United Kingdom.1 
Several studies, mainly in Mediterranean populations, have ex-
amined associations between siestas and health outcomes, in-
cluding myocardial infarction, stroke, and overall mortality. Two 
case-control studies in Greece reported inverse associations be-
tween the duration of siestas and the incidence of myocardial in-
farction without specifying the regularity of midday napping.2,3 
A case-control study in Costa Rica, in contrast, reported a posi-
tive association, especially for daily siestas lasting longer than 1 
hour.4 Two cohort studies in Israel reported positive associations 
of daily siestas with cardiovascular mortality,5,6 one suggesting 
stronger associations among men for longer siestas and stronger 
associations among women for shorter siestas.6 A recent Greek 
cohort study showed a protective effect of regular and occasional 
siesta (defined as at least 3 siestas per week) on the coronary mor-
tality among men only.7
These associations may have been distorted by confounding by 
unmeasured or poorly measured cardiovascular risk factors,6 sleep 
apnea (which is related to arterial hypertension and obesity8), and 
sleep disturbances at night. Consequently, one would expect to ob-
serve a higher prevalence of cardiovascular risk factors and noctur-
nal sleep disturbances among persons who take siestas.
Neither the prevalence of siesta habits nor associations among 
siesta habits, nocturnal habits, disturbances of sleep, and cardio-
vascular risk factors have been well characterized in northern 
European populations to date. In Germany, population-based 
prevalence estimates of nocturnal sleep disturbances are scant.9-11 
In addition, information appears to be unavailable for any popula-
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Background: Several studies have assessed the association between 
siesta and cardiovascular outcomes. Concern exists that confound-
ing might have distorted these results and contributed to discrepancies 
among them. This report examines the association between siesta hab-
its and cardiovascular risk factors, including sleep disturbances at night, 
depressed mood, and measures of subclinical atherosclerosis such as 
coronary calcium score and ankle brachial index. 
Methods: The baseline examination of 4,797 participants aged 45-74 
years included interviews, physical examinations, laboratory tests, and 
electron beam computed tomography. We compared the baseline preva-
lence of depressed mood, nighttime sleep disturbances, and health status 
in 3 categories of siesta habits: irregular or no siestas; daily short siestas 
(1 hour or less); and daily long siestas (>1 hour).  We also characterized 
cardiovascular risk factor distributions in the 3 siesta groups and conduct-
ed a sensitivity analysis of the potential for confounding by these factors 
in studies of incident cardiovascular disease. 
Results: Depressed mood and poor self-perceived health status at base-
line had positive associations with the age-standardized prevalence of daily 
long siestas among both men and women. Daily takers of long siestas had a 
considerably higher prevalence of cardiovascular risk factors in both sexes 
and appreciably worse measures of subclinical atherosclerosis in men only, 
in comparison with either of the other siesta groups. Daily long siestas had 
positive associations with prevalence of several cardiovascular risk factors 
and measures of subclinical atherosclerosis. 
Conclusions: If uncontrolled, these associations could produce appre-
ciable confounding in studies of siesta habits and incidence of cardiovas-
cular events. 
Keywords (MeSH): Cohort studies; sleep initiation and maintenance disor-
ders; risk factors; coronary arteriosclerosis; tomography, x-ray computed.
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tion on the association between siesta habits and measures of sub-
clinical atherosclerosis, including ankle brachial index (ABI) and 
coronary calcification as measured by electron beam computed 
tomography (EBT). 
We present results of a cross-sectional analysis of results from 
the baseline examinations in the ongoing Heinz Nixdorf Recall 
Study, a population-based prospective cohort study of the com-
parative predictive value of modern risk stratification techniques 
for coronary events.12,13 Our aims are to describe the prevalence 
of siesta habits in this population; to examine the associations of 
these habits with the baseline prevalence of depressed mood, noc-
turnal sleep disturbances, and self-perceived health status; and to 
assess the potential for confounding by cardiovascular risk fac-
tors, including subclinical atherosclerosis measures, in prospec-
tive studies relating baseline siesta habits to the incidence of car-
diovascular events.
MATERIAL AND METHODS
The rationale, design and methods of the Heinz Nixdorf Recall 
Study have been described in detail.12,13 Briefly, from December 
2000 through August 2003, we recruited 4,814 participants, aged 
45-75 years, residing in the industrial cities Essen, Bochum, and 
Mülheim, in the Ruhr area of Germany. Participants were drawn 
from mandatory residence lists, with a response rate of 56 percent. 
The participants are currently under follow-up until July 2008. 
The baseline examinations included interviews for cardiovas-
cular risk factors; anthropometric measurements such as height, 
weight, waist-to-hip ratio, blood pressure, and ankle brachial in-
dex (ABI); comprehensive laboratory tests of blood and urine; 
resting and exercise electrocardiograms; and electron beam 
computed tomography (EBT) to assess coronary calcium quanti-
ties.13 The study organization was certified according to DIN EN 
ISO9001:2000.14
Participants on antihypertensive medication or with systolic 
blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm 
Hg15 were defined as hypertensive. Participants were classified 
as having diabetes if they reported a history of diagnosis of the 
disease, took antidiabetic drugs, or had a nonfasting glucose level 
≥200 mg/dL. Participants with a self-reported history of coronary 
artery disease (myocardial infarction, revascularization of coro-
nary arteries including balloon dilatation, and coronary bypass 
surgery) were defined as having manifest CAD. 
We defined the presence of relevant coronary calcium as an 
Agatston score16 of 100 or higher.17,18 We considered high-sensi-
tive C-reactive protein (CRP) concentrations >3 mg/L as elevated 
values.19 ABI <0.9 was considered abnormal.20 Dyslipidemia was 
defined as either a total cholesterol ≥240 mg/dL, a HDL choles-
terol <40 mg/dL, or intake of lipid lowering drugs.21 Obesity was 
defined as a body mass index (BMI) ≥30 kg/m2. An increased 
waist circumference was defined as >102 cm among men and >88 
cm among women.21 
The interview on sleep habits included several questions on 
sleep duration, frequency and duration of siesta, and nocturnal 
sleep disturbances during the 4 weeks before interview: difficulty 
falling asleep (DFA), difficulty maintaining sleep (DMS), early 
morning arousal (EMA) during the 4 weeks before interview, and 
frequency and duration of siestas. We defined nocturnal sleep du-
rations <6 hours as excessively short and durations >8 hours as 
excessively long.22-26
Frequency of nocturnal sleep disturbances was assessed as 
never, sometimes (one or fewer per week), frequently (at least 
twice per week), and nearly every night. We defined persons hav-
ing prevalent nocturnal sleep disturbances if they occurred nearly 
every night.26 The frequency categories for siesta were never, <1 
per week, 1-4 per week, 5-6 per week, and daily. We defined sies-
tas taken ≥5 days per week as daily siestas and siestas taken less 
often as irregular.6,27 The latter group was combined with those 
reporting no siestas, as the cardiovascular risk factor prevalence 
was virtually identical in these groups. All participants who re-
ported siestas reported sleeping at night.
We assessed depressed mood with the Center for Epidemiolog-
ic Studies-Depression (CES-D) scale.28,29 We modified the CES-D 
by excluding the symptom “my sleep was restless” to remove the 
item’s correlation with questions on sleep disturbances or siesta 
frequency.30 Thus, the scale had 14 items and a range of 0-42. 
The question on self-perceived health status in the recent 12 
months had an ordinal scale: very good, good, satisfactory, less 
well, poor. Participants who rated their health as less well or poor 
were regarded as having reduced self-perceived health status.
Statistical Methods
Of the 4,472 non-CAD subjects aged 45-74 years, 4% had not 
undergone EBT scanning and 2% had missing data on ABI. All 
other risk factors included in the analyses had missing values of 
less than 1%. We calculated sex-specific and age-specific (45-54 
y, 55-64 y, and 65-74 y) prevalence estimates of siesta habits and 
nocturnal sleep disturbances. We calculated the average overall 
sleep duration per day as hours of sleep per week divided by 7. 
To classify participants without CAD with regard to depressed 
mood, we used the sex-specific 90th percentiles (men: ≥13, wom-
en: ≥17) of the modified score.
We calculated age-standardized prevalences with the age dis-
tribution of the overall non-CAD group as the standard (13% aged 
45-49 years, 19% aged 50-54 years, 18% aged 55-59 years, 22% 
aged 60-64 years, 16% aged 65-69 years, 11% aged 70-74 years). 
For the comparison of subjects taking daily siestas >1 hour in 
length with those never or irregularly taking siestas, or taking 
daily short siestas, we calculated sex-specific age-standardized 
prevalence ratios and 95% confidence intervals, with people tak-
ing no or irregular siestas serving as the reference group.
To quantify the presence of CAD risk factors, we created a 
count variable for the number of established risk factors at base-
line for each person in the non-CAD group. Ten risk factors were 
included in this count: age (≥60 years), smoking, diabetes melli-
tus, hypertension, dyslipidemia, obesity, increased waist circum-
ference, increased CRP, increased coronary calcium score, and 
abnormal ABI according to the definitions given above. We used 
these counts in a sensitivity analysis to assess the potential for 
confounding by CAD risk factors in prospective studies of base-
line siesta in relation to incident CAD. 
Starting with a 10-year CAD risk of 0.02 from the Framing-
ham prediction model for persons aged 53 years with no Fram-
ingham risk factors, we used the exponential formula, R = 1 
– exp(-It) (where R is the 10-year risk, I is the incidence rate and 
t=10 years) to convert this risk to a baseline rate of 20.3 CAD 
cases per 10,000 person-years. For simplification, we assumed 
that siesta has no effect on the CAD incidence rate and that 
each potentially confounding risk factor has the same rate ratio, 
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which we specified as 1.3, 1.5, 1.7, and 2.0 in separate analyses. 
We additionally assumed constancy of each risk factor’s rate ra-
tio within strata of all the other risk factors. This mirrors the 
routine assumption when potential confounders are specified 
only as main effects, without product interactions among them, 
in multiple regression models. Thus, in the analysis in which 
the risk factors were assumed to have a rate ratio of 1.5, the rate 
ratio contrasting persons with 5 of the 10 risk factors to those 
with none was 1.55 = 7.6. 
In the first sensitivity analysis, we assumed adjustment for none 
of the risk factors (i.e., a crude analysis). In the second analysis, 
we assumed adjustment for age and removed age from the count 
variable, thereby reducing the theoretical maximum for this vari-
able to 9. In the third analysis, we assumed adjustment for age 
and smoking, removed age and smoking from the count variable, 
and reduced the theoretical maximum to 8. We then added hy-
pertension, diabetes and waist circumference to the fourth, fifth, 
and sixth analyses, respectively, in a similar fashion. From the 
observed distributions of the risk factor count variable, we were 
thus able to project hypothetical CAD rates for each of the 3 siesta 
groups. Under the assumption of no siesta effect on CAD, the 
rate ratios obtained from these hypothetical rates provide an ap-
proximate indication of the direction and magnitude of potential 
confounding. 
 RESULTS
Overall, 325 subjects aged 45-74 years (7%) had a history of 
CAD. Table 1 presents sleep characteristics of participants with-
out a history of CAD. The median sleep duration at night did 
not vary by age and sex, but elderly women more often tended 
to sleep <6 hours per night than elderly men. The prevalence of 
all nocturnal sleep disturbances was considerably higher among 
women than among men, regardless of age. The most frequently 
reported regular sleep disturbance among men and women was 
difficulty maintaining asleep at night among both. The prevalence 
of the 3 major types of nocturnal sleep disturbances increased 
monotonically with age among women. The prevalence of daily 
siesta was slightly higher among men than women, regardless of 
age. The median duration of siesta among daily siesta takers was 
particularly long in older men, among whom siestas contributed 
appreciably to the total daily sleep duration. 
Table 2 presents the sleep characteristics of the 325 participants 
with a history of CAD. Because only 68 women had manifest 
CAD, age-specific estimates of sleep characteristics in that group 
are not shown. Women with CAD had a considerably higher prev-
alence of excessively short sleep durations (<6 h) than men with 
CAD. Difficulty falling asleep and early morning arousal were 
more prevalent among women than men, whereas the prevalence 
of difficulty maintaining sleep was about the same in the 2 sexes. 
Generally, prevalence of siesta and of nocturnal sleep disturbanc-
es were higher among participants who had CAD than among 
those who did not.
Poor self-perceived health status, depressive mood, difficul-
ties falling asleep, and excessively short nocturnal sleep dura-
tions were positively associated with daily long siestas among 
both men and women. Early morning awakening was negatively 
associated with regular siesta among men and positively associ-
ated with regular siesta among women (Table 3). 
Participants taking short daily siestas showed prevalence of 
CAD risk factors similar to those of participants who took sies-
tas no more than occasionally (Table 4). Participants taking daily 
long siestas, however, showed higher prevalence of CAD risk 
factors, and, especially in men, higher prevalence of subclinical 
atherosclerosis as measured by ABI and EBT. The overall number 
of established CAD risk factors was higher among subjects tak-
ing daily long siestas compared with subjects taking daily short 
siestas, irregular siestas, or no siestas.
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Table 1—Sleep Characteristics and Sleep Disturbances Among 4,472 Men and Women of the Heinz Nixdorf Recall Study, Aged 45-74 Years, With 
No History of Coronary Artery Disease
    Average Overall 
  Sleep Disturbances nearly   Sleep Duration
 Sleep Duration at Night every night (%)a Daily Siesta  (night & siesta)b
 N Median <6h/ >8h/ DFA DMS EMA Any (%) >1h/day  Median  Median (min)
   (min) night  night     (%) (min)c 
   (%) (%)
Men           
All (crude) 2132 420 10.6 6.9 7.0 32.3 8.1 16.7 3.1 60 422
All (age-stand.)   9.9 6.5 6.5 30.4 7.5 15.8 2.9  
45-54 yrs 707 420 12.7 3.4 6.6 16.3 6.7 7.4 1.3 45 420
55-64 yrs 852 420 11.5 6.9 8.4 35.4 10.2 15.4 3.2 60 424
65-74 yrs 573 420 6.8 11.2 5.6 47.5 6.7 30.1 5.1 60 460
Women           
All (crude) 2340 420 15.5 7.1 11.7 38.7 12.2 15.1 1.9 30 420
All (age-stand.)   14.4 6.6 10.9 36.0 11.3 14.0 1.7  
45-54  yrs 743 420 14.3 2.7 10.0 28.1 11.3 6.2 1.2 45 420
55-64  yrs 933 420 15.6 8.7 11.9 42.6 12.2 13.9 1.2 30 420
65-74  yrs 664 420 16.6 9.7 13.5 45.2 13.1 26.9 3.6 45 429
aDFA: difficulties falling asleep; DMS: difficulties maintaining sleep; EMA: early morning arousal
bOverall sleep duration including sleep at night and siesta of any frequency per week
cMedian duration of siesta (minutes) among subjects with daily siesta
 Missing data: per Item < 1%, therefore missing data were excluded.
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In a hypothetical follow-up study of a cohort with the risk fac-
tor distributions of the 3 siesta groups in the Heinz Nixdorf Re-
call Study, the estimated rate ratios for the association between 
baseline siesta and incident CAD are appreciably confounded 
upon adjustment for few or no risk factors, among both men and 
women (Table 5). The adjusted estimates move closer to the hy-
pothetically unconfounded null value upon adjustment for addi-
tional numbers of risk factors.
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Table 3—Age-Standardized Prevalence of Self-Perceived Poor Health Status, Depressive Mood, Regular Nocturnal Sleep Disturbances, and 
Excessively Short and Long Nocturnal Sleep Duration by Type of Siesta Taker Among 4,472 Subjects Without Manifest Coronary Artery Disease 
of the Heinz Nixdorf Recall Study, Germany, 2000-2003
 Irregular or No  Daily Short Daily Long  Daily Short Siesta vs. Daily Long Siesta vs. 
 Siesta  Siesta Siesta  Irregular or No Siesta Irregular or No Siesta
      Standardized Prevalence Standardized Prevalence 
 Number of Men  n=1770 n=290 n=65  Ratio (SPR) Ratio (SPR)
  n % n % n % SPR 95%CI SPR 95%CI
 Poor Health Status 211 11.3 29 8.8 12 20.2 0.78 0.71-0.86 1.79 1.38-2.32
 Depressive Mood 176 9.3 33 11.7 15 23.1 1.26 1.15-1.37 2.48 1.99-3.09
 Regular DFA 118 6.2 24 8.1 7 11.5 1.31 1.16-1.49 1.85 1.17-2.95
 Regular DMS 541 30.0 120 32.8 24 31.1 1.09 1.07-1.12 1.04 0.92-1.17
 Regular EMA 148 7.8 21 6.4 2 4.1 0.82 0.72-0.94 0.53 0.19-1.43
 Sleep duration < 6h/night 190 9.8 30 10.4 6 16.2 1.06 0.96-1.17 1.65 1.13-2.41
 Sleep duration >8h/night 112 6.2 29 7.7 6 6.8 1.24 1.12-1.37 1.10 0.73-1.65
 Number of Women n=1981  n=308  n=44     
 Poor Health Status 369 17.4 77 23.5 14 27.2 1.35 1.29-1.41 1.56 1.25-1.95
 Depressive Mood 196 9.5 28 8.0 6 15.0 0.84 0.75-0.95 1.58 0.99-2.52
 Regular DFA 219 10.4 42 12.2 12 30.4 1.17 1.09-1.27 2.92 2.25-3.80
 Regular DMS 747 35.5 136 36.6 20 45.8 1.03 1.01-1.06 1.29 1.11-1.49
 Regular EMA 218 10.3 56 19.6 8 23.2 1.90 1.79-2.02 2.25 1.53-3.31
 Sleep duration < 6h/night 294 14.0 53 18.4 12 36.1 1.31 1.23-1.41 2.58 2.06-3.22
 Sleep duration >8h/night 135 6.6 23 5.6 7 11.0 0.85 0.75-0.96 1.67 1.18-2.36
N=14 subjects were excluded because information on siesta duration was missing; poor health status: self-perceived health status rated as “less well” 
or “poor”; depressive mood as measured by a modified CES-D score; regular DFA: regular difficulties falling asleep; regular DMS: regular difficul-
ties maintaining sleep; regular EMA: regular early morning awakening; SPR: Standardized prevalence ratio; ratio of age-standardized prevalences; 
CI: Confidence interval.
Table 2—Sleep Characteristics and Sleep Disturbances Among 325 Men and Women of the Heinz Nixdorf Recall Study, Aged 45-74 Years, With 
a History of Coronary Artery Disease
    Average Overall 
  Sleep Disturbances nearly   Sleep Duration
 Sleep Duration at Night every night (%)a Daily Siesta  (night & siesta)b
 N Median <6h/ >8h/ DFA DMS EMA Any (%) >1h/day  Median  Median (min)
   (min) night  night     (%) (min)c 
   (%) (%)
Men           
All (crude) 257 420 16.0 10.5 12.5 46.1 13.4 30.5 8.2 60 426
All (age-stand.)   17.1 7.6 13.7 39.6 13.0 22.2 5.8  
45-54 yrs 38 390 18.4 5.3 13.2 31.6 21.1 13.2 0 60 416
55-64 yrs 88 420 20.7 9.2 18.4 47.1 11.6 21.8 9.2 60 420
65-74 yrs 131 420 12.2 13.0 8.4 49.6 12.3 41.2 9.9 60 435
Women           
All (crude) 68 420 27.9 7.4 25.4 58.8 17.9 25.0 4.4 60 420
All (age-stand.)   28.4 9.8 25.3 41.9 17.2 14.2 2.4  
aDFA: difficulties falling asleep; DMS: difficulties maintaining sleep; EMA: early morning arousal
bOverall sleep duration including sleep at night and siesta of any frequency per week
cMedian duration of siesta (minutes) among subjects with daily siesta
 Missing data: per Item < 1%, therefore missing data were excluded.
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Table 4—Age-Standardized Prevalence of Cardiovascular Risk Factors Stratified by Type of Siesta Taker Among 4,472 Subjects Without Manifest 
Coronary Artery Disease of the Heinz Nixdorf Recall Study, Germany, 2000-2003
 Irregular or No  Daily Short Siesta Daily Long  Daily Short Siesta vs. Daily Long Siesta vs. 
 Siesta  Siesta  Irregular or No Siesta Irregular or No Siesta
Number of Men     Standardized Prevalence Standardized Prevalence 
   n=1770 n=290 n=65  Ratio (SPR) Ratio (SPR)
  n % n % n % SPR 95%CI SPR 95%CI
Age ≥60 yearsa 794 44.9 207 71.4 48 73.9 1.59 1.31-1.94 1.65 1.12-2.41
Hypertension 798 43.3 152 43.5 33 34.1 1.00 0.99-1.02 0.79 0.73-0.85
Current Smokers 463 23.5 67 25.3 25 41.5 1.08 1.03-1.12 1.77 1.57-1.99
Diabetes mellitus 155 8.5 29 7.2 12 13.5 0.85 0.77-0.93 1.59 1.25-2.02
Dyslipidemia 977 52.1 155 51.6 34 43.7 0.99 0.97-1.01 0.84 0.77-0.91
BMI ≥ 30 kg/m2 456 24.4 76 22.8 21 27.6 0.93 0.90-0.97 1.13 0.99-1.29
Waist Circumference >
102 cm 682 36.7 119 35.5 33 41.5 0.97 0.94-0.99 1.13 1.04-1.23
CRP> 3 mg/L 358 19.3 62 18.7 25 34.3 0.97 0.92-1.02 1.78 1.60-1.97
Agatston Score ≥ 100 642 37.0 138 37.9 40 48.0 1.02 1.00-1.05 1.30 1.22-1.38
ABI < 0.9 74 4.3 22 6.4 10 12.0 1.49 1.28-1.73 2.79 2.15-3.62
 Number of Modifiable Cardiovascular Risk Factorsb
0 155 8.3 13 5.5 1 6.2 0.66 0.54-0.81 0.75 0.10-5.38
1 297 16.3 46 17.3 8 16.0 1.06 1.00-1.13 0.98 0.65-1.49
2 382 22.0 56 21.4 10 14.3 0.97 0.92-1.02 0.65 0.49-0.87
3 358 20.1 73 21.7 13 19.6 1.08 1.04-1.12 0.98 0.80-1.18
4 234 13.6 45 15.1 8 12.1 1.11 1.04-1.18 0.89 0.66-1.20
5 139 8.3 27 9.0 13 16.1 1.08 0.96-1.22 1.94 1.59-2.37
6 60 3.6 13 3.0 5 4.9 0.83 0.68-1.03 1.36 0.85-2.18
7 16 1.0 1 0.2 2 2.7 0.20 0.05-0.84 2.70 0.69-10.53
8 2 0.1 1 0.2 2 1.2 2.00 0.05-74.83 12.00 1.11-129.41
9 0  0  0      
 Number of Women n=1981 n=308 n=44     
  n % n % N %    
Age ≥ 60 yearsa 918 46.3 223 72.4 32 72.7 1.56 1.29-1.89 1.57 0.99-2.49
Hypertension 588 28.3 113 29.0 15 28.2 1.02 1.00-1.05 1.00 0.81-1.22
Current Smokers 438 19.8 50 19.1 11 29.3 0.96 0.91-1.03 1.48 1.20-1.82
Diabetes mellitus 118 5.8 16 3.6 8 17.8 0.62 0.53-0.72 3.07 2.18-4.33
Dyslipidemia 994 47.8 167 43.8 29 57.0 0.92 0.90-0.93 1.19 1.07-1.32
BMI ≥ 30 kg/m2 540 25.9 93 25.7 17 34.5 0.99 0.96-1.03 1.33 1.10-1.61
Waist Circumference > 
88 cm 898 43.1 164 43.7 27 55.3 1.01 0.99-1.04 1.28 1.15-1.44
CRP> 3 mg/L 446 21.3 69 17.1 10 21.2 0.80 0.77-0.83 1.00 0.77-1.29
Agatston Score ≥ 100 271 13.9 63 13.2 8 12.8 0.95 0.91-0.99 0.92 0.63-1.35
ABI < 0.9 90 4.5 19 4.9 2 2.2 1.09 ß-94-1.27 0.49 0.17-1.42
Number of Modifiable Cardiovascular Risk Factorsc       
0 272 13.2 31 16.1 1 3.5 1.22 1.11-1.34 0.27 0.04-1.81
1 427 21.1 58 18.9 10 23.4 0.90 0.85-0.94 1.11 0.86-1.43
2 439 22.0 69 23.0 6 18.3 1.05 1.00-1.09 0.83 0.56-1.23
3 319 16.2 53 14.9 9 19.2 0.92 0.87-0.97 1.19 0.81-1.73
4 233 12.0 46 13.6 6 10.1 1.13 1.05-1.22 0.84 0.52-1.36
5 114 5.9 23 4.9 6 10.4 0.83 0.75-0.92 1.76 1.10-2.82
6 41 2.1 6 1.1 3 8.5 0.52 0.36-0.75 4.05 1.72-9.55
7 12 0.6 2 0.6 0  1.00 0.32-3.11
8 3 0.2 1 0.3 0  1.50 0.10-22.17
9 0  0  0
 N=14 subjects were excluded because information on siesta duration was missing; poor health status: self-perceived health status rated as “less well” 
 or “poor”; depressive mood as measured by a modified CES-D score; regular DFA: regular difficulties falling asleep; regular DMS: regular difficulties 
 maintaining sleep; regular EMA: regular early morning awakening; SPR: Standardized prevalence ratio; ratio of age-standardized prevalences.
a prevalences of age ≥ 60 years are crude prevalences; prevalence ratio of crude prevalences. 
b due to missing data of either of the 9 modifiable risk factor, the overall N of male irregular or no siesta takers is 1643, of daily short takers is
 275 and of daily long takers is 62. 
c due to missing data of either of the 9 modifiable risk factor, the overall N of female irregular or no siesta takers is 1860, of daily short takers is
 289 and of daily long takers is 41.
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Table 5—Hypothetical Coronary Artery Disease Rate Ratio Estimates Adjusted for Varying Numbers of CAD Risk Factors in a Hypothetical 
Cohort with Risk Factor Distributions Like Those Of The Siesta Groups in the Heinz Nixdorf Recall Study
Assumed rate 
ratio for each  Estimated 10-year Rate Ratios of 
risk factora Adjustment set Coronary Artery Disease
 No/irregular  Daily Daily
 siesta  Short siesta Long siestaMen
    
1.3 None Reference Group 1.14 1.45
 Age Reference Group 1.00 1.17
 Age & smoking Reference Group 0.99 1.09
 Age, smoking & diabetes Reference Group 1.00 1.08
 Age, smoking, diabetes & hypertension Reference Group 1.02 1.10
 Age, smoking, diabetes, hypertension & waist Reference Group 1.01 1.10
    
1.5 None Reference Group 1.20 1.76
 Age Reference Group 1.00 1.28
 Age & smoking Reference Group 0.98 1.16
 Age, smoking & diabetes Reference Group 1.00 1.14
 Age, smoking, diabetes & hypertension Reference Group 1.03 1.18
 Age, smoking, diabetes, hypertension & waist Reference Group 1.01 1.17
    
1.7 None Reference Group 1.24 1.98
 Age Reference Group 0.99 1.38
 Age & smoking Reference Group 0.97 1.22
 Age, smoking & diabetes Reference Group 1.00 1.20
 Age, smoking, diabetes & hypertension Reference Group 1.04 1.24
 Age, smoking, diabetes, hypertension & waist Reference Group 1.00 1.23
    
2.0 None Reference Group 1.29 2.06
 Age Reference Group 0.99 1.43
 Age & smoking Reference Group 0.96 1.27
 Age, smoking & diabetes Reference Group 0.99 1.25
 Age, smoking, diabetes & hypertension Reference Group 1.04 1.33
 Age, smoking, diabetes, hypertension & waist Reference Group 1.00 1.32
Women
    
1.3 None Reference Group 1.13 1.28
 Age Reference Group 0.98 1.16
 Age & smoking Reference Group 0.98 1.20
 Age, smoking & diabetes Reference Group 0.99 0.98
 Age, smoking, diabetes & hypertension Reference Group 0.98 0.99
 Age, smoking, diabetes, hypertension & waist Reference Group 0.97 0.98
    
1.5 None Reference Group 1.20 1.43
 Age Reference Group 0.96 1.26
 Age & smoking Reference Group 0.96 1.36
 Age, smoking & diabetes Reference Group 0.97 0.97
 Age, smoking, diabetes & hypertension Reference Group 0.96 0.98
 Age, smoking, diabetes, hypertension & waist Reference Group 0.95 0.96
    
1.7 None Reference Group 1.25 1.57
 Age Reference Group 0.95 1.35
 Age & smoking Reference Group 0.94 1.50
 Age, smoking & diabetes Reference Group 0.96 0.96
 Age, smoking, diabetes & hypertension Reference Group 0.95 0.96
 Age, smoking, diabetes, hypertension & waist Reference Group 0.93 0.93
    
2.0 None Reference Group 1.30 1.72
 Age Reference Group 0.94 1.46
 Age & smoking Reference Group 0.92 1.65
 Age, smoking & diabetes Reference Group 0.94 0.95
 Age, smoking, diabetes & hypertension Reference Group 0.92 0.94
 Age, smoking, diabetes, hypertension & waist Reference Group 0.91 0.90
a Risk factors adjusted for were: age, smoking, diabetes, hypertension, dyslipidemia, obesity, waist, CRP, Agatston score, ABI; all risk factors are 
treated as dichotomous variables; we assumed that siesta has no effect on the CAD incidence 
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DISCUSSION
In our sample, the small number of participants who took daily 
long siestas were older, disproportionately male, and had a relative-
ly high prevalence of manifest CAD, depressed mood, and low self-
perceived health status in comparison with those who took shorter 
siestas and with those who took siestas irregularly or never. In the 
subset of participants lacking manifest CAD at baseline, the tak-
ing of daily long siestas was associated with increased prevalence 
of most CAD risk factors and with unfavorable distributions of 2 
subclinical CAD measures: ABI and coronary calcium score. These 
results corroborate recent epidemiologic findings in Costa Rica and 
Israel4,27 that daily takers of relatively long siestas constitute a high-
risk group. It is unclear whether these findings contradict the Greek 
case-control studies, because regularity of midday napping was not 
reported in those studies.2,3 
Naska et al7 studied the association between siesta and coronary 
mortality in a population-based study in Greece among 17,086 
men and 23,380 women, aged 20-86 years. Although the investi-
gators assessed the mean siesta duration, they did not report the 
association between long regular siestas and coronary mortality. 
It has been hypothesized that long siestas are associated with in-
creased risk of cardiovascular mortality and incident myocardial 
infarction.4,6 Several factors hamper a comparison of our results 
with those from Naska et al. They excluded patients with histories 
of cancer or angina, used a different definition of regular siestas, 
and adjusted for 3 additional variables (physical activity, Mediter-
ranean diet score, and employment status). 
The prevalence of regular siesta in our study was considerably 
lower than in studies that investigated the association between si-
esta habits and coronary heart disease in Costa Rica and Israel. 
In Costa Rica, for example, Burazeri et al reported a prevalence 
of regular siestas of 41% among men and 33% among women. 
Among persons of similar age in our study, the prevalence was 
16% in both sexes.6 The prevalence of taking siestas at least once 
per week was 70% in Costa Rica (control group) and 51% in our 
study among subjects without manifest CAD.4 A higher preva-
lence of siesta-taking among participants with manifest CAD has 
also been observed by others.5,6,27 This may indicate, at least in 
part, that siesta is a consequence of CAD, for the simple reason 
that persons with CAD may be sick and tired.
Those who take daily, long siestas are of concern not only clini-
cally, but with regard to potential confounding in studies of siesta-
taking in relation to incident cardiovascular outcomes. Burazeri et 
al6 observed increased cardiovascular mortality among men, but 
not women, who took daily siestas of very long duration (at least 
2 hours per day). There were not enough participants in our study 
who took daily siestas of this length to support a meaningful analy-
sis. Nevertheless, though Burazeri et al adjusted for some cardio-
vascular risk factors, our sensitivity analyses suggest that residual 
confounding by additional risk factors might have contributed ap-
preciably not only to that association, but to associations in studies 
in which the takers of daily, long siestas were grouped with those 
taking less regular siestas, shorter siestas, or both.5 
The finding that one CAD risk factor, hypertension, is inversely 
associated with the taking of daily, long siestas at baseline among 
men in our cohort indicates that the confounding of associations 
between siesta and cardiovascular outcomes is not of necessity up-
ward. The magnitude and even the direction of the net confounding 
by unmeasured, poorly measured, or incompletely specified CAD 
risk factors may vary from place to place and from time to time. 
Thus, we recommend that sensitivity analyses of uncontrolled con-
founding31,32 be conducted for all previous studies of this topic as 
well as future studies. The best time to conduct these sensitivity 
analyses would be before collecting any data, in the design phase of 
a study, to guide the breadth and depth of data collection on poten-
tial confounders. The simple assumptions of the same rate ratio for 
each risk factor and of a multiplicative relation among multiple risk 
factors in our sensitivity analyses could be replaced by evidence-
based estimates from systematic literature reviews of the specific 
unmeasured risk factors of concern in a given study.
Additional studies on siesta habits in relation to measures of 
subclinical atherosclerosis are needed to compare with our re-
sults. The adverse distributions of coronary calcium and ABI we 
observed among men taking daily long siestas suggest that the 
atherosclerotic burden is particularly high in this group.
Of equal importance to the potential identification of takers of 
daily long siestas as a special high-risk group is the implication 
that persons taking daily siestas of shorter duration do not stand 
out in our results. In every analysis, this group was more similar to 
those who took no siestas or who took siestas irregularly than to the 
special group who took daily long siestas. The extent to which this 
result might be generalizable to other populations is unknown and 
should be determined in studies of populations in different climates 
and cultures, including reanalyses of existing data.
There is evidence from several prospective cohort studies that 
depression is a risk factor for CAD.33 Depressed mood was posi-
tively associated with siesta-taking in our cross-sectional data. 
Thus, confounding by depression may further complicate the 
study of the association between siesta-taking and cardiovascular 
disease incidence. Ohayon et al found that severe daytime sleepi-
ness, which is not necessarily a surrogate for daily siesta-taking, 
was associated with prevalence of depressive disorder.34 To our 
knowledge, none of the prospective studies on siesta and car-
diovascular disease incidence or mortality have adjusted for de-
pressed mood. The relationship is further complicated by the fact 
that sleep problems can contribute to the diagnosis of depressive 
disorder. Our approach to this problem was to remove the sleep 
item from the depressive symptom scale we used. This strategy 
may not always be possible (e.g., with clinically diagnosed major 
depressive disorder). 
Self-perceived poor health is a correlate of nocturnal sleep dis-
turbances.35-37 Like Burazeri et al,6 we found that self-perceived 
poor health is associated with daily siestas of long duration. This 
result further supports the view that it may not be siesta itself but 
cardiovascular risk factors, subclinical atherosclerosis, and other 
diseases that explain higher observed cardiovascular risks among 
daily takers of long siestas. The observation of Bursztyn et al that 
not only increased cardiovascular disease mortality, but increased 
mortality from non-malignant, non-cardiovascular diseases as 
well, corroborates this hypothesis.5
We found evidence of little or no association between the fre-
quency of nocturnal sleep disturbances (difficulties falling asleep, 
maintaining asleep, early morning arousal) and siesta frequency. 
We found that daily short and long siestas were associated with 
regular difficulties falling asleep at night, suggesting that the tak-
ing of daily siestas might represent compensation for poor noc-
turnal sleep quality. Bursztyn et al found that siesta-taking was 
associated with increased nocturnal sleep satisfaction,5 but they 
did not specifically examine daily long siestas separately.
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There are several factors that limit our results. First, the informa-
tion on sleep habits came from self-reports and was not validated. 
Second, the interview questions did not draw a distinction between 
voluntary and involuntary afternoon naps (i.e., falling asleep while 
intending to remain awake). In addition, we did not ask for the con-
text in which napping is most common, such as the typical time 
during the day for napping, nap environment (e.g., light and noise 
level), mode of awakening, sleepiness after awakening, and sleep 
satisfaction. Third, obesity, snoring, and daytime sleepiness have 
been reported to be key markers of sleep apnea,38-40 which is plau-
sibly associated with siesta-taking. We were unable to assess the 
association between obstructive sleep apnea and siesta-taking be-
cause we did not collect information on snoring and sleep apnea. 
The weak association between siesta-taking and obesity may reflect 
at least some of the consequences of sleep apnea. 
In conclusion, daily long siestas are associated with poor self-
perceived health status, depressive mood, and regular difficul-
ties falling asleep among men and women in this cross-sectional 
sample. Daily long siestas are associated with excessively short 
and long sleep durations and with early morning awakening 
among women. Daily long siestas are also associated with sev-
eral cardiovascular risk factors and with measures of subclinical 
atherosclerosis among men and women. These associations may 
complicate prospective studies of siesta-taking in relation to inci-
dent cardiovascular disease by creating confounding, which our 
sensitivity analyses suggest may be difficult to control adequately. 
Daily short siestas and irregular siestas were not strongly asso-
ciated with increased prevalence of cardiovascular risk factors, 
subclinical atherosclerosis, or sleep disturbances in our study. The 
taking of infrequent or relatively short siestas, therefore, may not 
be indicative of preclinical cardiovascular disease or of risk factor 
clustering and may thus be innocuous.
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